Do Patients with Stage I/II Melanoma Attend Follow-up Visits as Often as Recommended by Guidelines?
Memari N, Hayen A, Bell KJL, Rychetnik L, Morton RL, McCaffery K, Thompson JF, Irwig L, Turner RM
DOI 10.1245/s10434-015-4589-x
DOI 10.1245/s10434-015-4589-x